findmyKOL
Clinical trialNCT06441435CompletedInterventional

The Effect of AC-134 in Chronic Kidney Diseases

SponsorTaichung Veterans General HospitalEnrollment100Nephrology
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective is to explore the effects of adding AC-134 on renal function, proteinuria, uremic toxins, and metabolism-related markers in chronic kidney disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Cheng-Hsu Chen, MDPHD

    Division of Nephrology in Taichung Veterans General Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Taichung Veterans General Hospital

    Taichung, ROC, Taiwan

  • Taichung Veterans General Hospital.

    Taichung, ROC, Taiwan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jun 2024
Primary completion
11 Jun 2025
Completion
30 Jun 2025
Last update posted
12 Jun 2026
Registered enrollment
100
Registry id
NCT06441435

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.